Advanta VXT Vascular Graft, Flixene Vascular Graft
K-Number: K231972 · 2024-03-28
Device Summary
Frequently Asked Questions
What is the Advanta VXT Vascular Graft, Flixene Vascular Graft?
Advanta VXT Vascular Graft, Flixene Vascular Graft is a medical device that received FDA 510(k) clearance on 2024-03-28. The listed applicant is Atrium Medical Corporation. The 510(k) number is K231972.
When did Advanta VXT Vascular Graft, Flixene Vascular Graft receive FDA 510(k) clearance?
Advanta VXT Vascular Graft, Flixene Vascular Graft received FDA 510(k) clearance on 2024-03-28, under 510(k) number K231972.
Who is the listed applicant for Advanta VXT Vascular Graft, Flixene Vascular Graft?
The FDA 510(k) record lists Atrium Medical Corporation as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Advanta VXT Vascular Graft, Flixene Vascular Graft?
The FDA product code for Advanta VXT Vascular Graft, Flixene Vascular Graft is DSY.
Other records listing Atrium Medical Corporation as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: DSY)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.